Durolane SJ - Synovial fluid supplementation substance Австралия - английский - Department of Health (Therapeutic Goods Administration)

durolane sj - synovial fluid supplementation substance

emergo asia pacific pty ltd t/a emergo australia - 44757 - synovial fluid supplementation substance - durolane sj contains 20 mg/ml of stabilized non-animal hyaluronic acid in buffered physiological sodium chloride solution ph 7. durolane sj is presented in a 1ml glass syringe with a rigid cap and plunge stopper. the syringe is assembled with a luer-lock adapter, finger grip and plunger rod. durolane sj is injected into the synovial joint by an authorized person experienced in intraarticular injections following an aseptic technique using an 18 to 22 gauge needle (not supplied). intended to be used for intra-articular injection for symptomatic treatment associated with mild to moderate osteoarthritis pain in the ankle, elbow, wrist, fingers, and toes. durolane sj is also indicated for pain following joint arthroscopy in the presence of osteoarthritis within three months of the procedure.

CINGAL? - Cross-linked Hyaluronic Acid with ancillary Triamcinolone Hexacetonide - Synovial fluid supplementation substance Австралия - английский - Department of Health (Therapeutic Goods Administration)

cingal? - cross-linked hyaluronic acid with ancillary triamcinolone hexacetonide - synovial fluid supplementation substance

surgical specialties pty ltd - 44757 - synovial fluid supplementation substance - cingal? is an off-white, opaque, sterile, single-use suspension of a cross-linked ha gel and an ancillary corticosteroid, th. cingal? is biocompatible and non-pyrogenic. the cross-linked ha and th in cingal? do not physically or chemically interact, as micronized particles of the th are suspended in the viscoelastic ha gel and reside in the product as a separate solid phase. cingal? is indicated as a viscoelastic supplement or a replacement for synovial fluid in the knee. cingal? is well suited for rapid and long term relief of the symptoms of knee joint dysfunctions such as osteoarthritis. the actions of cingal? are long term relief of symptoms by lubrication and mechanical support supplemented by short-term pain relief provided by triamcinolone hexacetonide.

ADANT - Synovial fluid supplementation substance Австралия - английский - Department of Health (Therapeutic Goods Administration)

adant - synovial fluid supplementation substance

bioinnova pty ltd - 44757 - synovial fluid supplementation substance - a sterile 1% sodium hyaluronate solution in prefilled glass syringe, with luer lock system for intra-articular use. single dose preparation for injection once per treatment course. adant is intended for intra-articular use to treat pain associated with osteoarthritis of the knee. adant improves articular mobility and normalises diseased synovia, thus relieving pain in the affected knee.

BETNOVATE N Ирландия - английский - HPRA (Health Products Regulatory Authority)

betnovate n

glaxo laboratories limited - betamethasone valerate neomycin sulfate - ointment - 0.1/0.5 %w/w

BETNOVATE-N 0.1% / 0.5% W/W CREAM Ирландия - английский - HPRA (Health Products Regulatory Authority)

betnovate-n 0.1% / 0.5% w/w cream

glaxosmithkline (ireland) limited - betamethasone valerate neomycin sulfate - cream - 0.1/0.5 %w/w

NOVIAL Film Coated Tablet Ирландия - английский - HPRA (Health Products Regulatory Authority)

novial film coated tablet

organon (ireland) limited - desogestrel ethinylestradiol - film coated tablet

NOVIAL 28 Ирландия - английский - HPRA (Health Products Regulatory Authority)

novial 28

organon (ireland) limited - desogestrel ethinylestradiol - film coated tablet